Efficacy of Interventional Methods Used in the Treatment of Coccydynia
Launched by ANKARA ETLIK CITY HOSPITAL · Oct 20, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into new treatments for coccydynia, which is pain in the tailbone area that hasn't improved with standard care. The study will compare two specific procedures: the sacral erector spinae plane block and the caudal epidural injection. Both of these methods are designed to relieve pain by targeting the nerves in the lower back and tailbone area. To make sure the procedures are done accurately, ultrasound and fluoroscopy (a type of real-time X-ray) will be used. Participants will share their experiences and pain levels through questionnaires at different points over 12 weeks to see how well these treatments work.
To be eligible for this trial, participants need to be between 18 and 70 years old and have been suffering from coccydynia that hasn't responded to other treatments. People who have had similar procedures before, have certain medical conditions, or are pregnant won’t be able to join. The study is not yet recruiting participants, but if you or someone you know is dealing with this kind of pain and meets the criteria, this could be an opportunity to explore new options for relief.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic coccydynia unresponsive to conservative treatment
- • Male and female population aged 18-70
- • No previous interventional procedure performed during the treatment process
- Exclusion Criteria:
- • Coagulation disorders
- • Infections in the areas to be treated
- • Allergy to local anesthesia
- • Socio-cultural inadequacy
- • Mental retardation
- • Pregnancy
- • Previous interventional procedure performed
- • Patient refusal of the interventional procedure
- • Presence of malignancy in the coccygeal region
- • Previous surgery in the coccygeal region
About Ankara Etlik City Hospital
Ankara Etlik City Hospital is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital emphasizes a multidisciplinary approach, leveraging its state-of-the-art facilities and a team of experienced healthcare professionals. With a commitment to ethical practices and patient safety, Ankara Etlik City Hospital aims to contribute to the global medical community by facilitating research that enhances treatment options and health outcomes across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Etlik, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported